MIC drop at #ESCCongress
No difference at all with revascularization in patients with ischemic cardiomyopathy.
There is silence in the audience! Woooowwwwww
@mmamas1973 @DrMarthaGulati @mirvatalasnag @iamritu @djc795 @SrihariNaiduMD @adityadoc1 @KemalogluOz @Hragy
No difference at all with revascularization in patients with ischemic cardiomyopathy.
There is silence in the audience! Woooowwwwww
@mmamas1973 @DrMarthaGulati @mirvatalasnag @iamritu @djc795 @SrihariNaiduMD @adityadoc1 @KemalogluOz @Hragy
https://twitter.com/purviparwani/status/1563498430907166724
#ESCCongress
Conclusions of #REVIVED trial —
In Patients with ICM — PCI didn’t reduce the all cause mortality or heart failure hospitalization at 3.4 years.
( including left main disease)
@DmitryAbramovMD @VinoyPrasadMD @adityadoc1 @datsunian @DineshKalra @DrSharathS
Conclusions of #REVIVED trial —
In Patients with ICM — PCI didn’t reduce the all cause mortality or heart failure hospitalization at 3.4 years.
( including left main disease)
@DmitryAbramovMD @VinoyPrasadMD @adityadoc1 @datsunian @DineshKalra @DrSharathS
Excellent discussion at #ESCCongress
REVIVED trial
💥 GDMT works — 90% on BB &ARNI/ACE/ ARB
💥 LVEF increase with PCI doesn’t help with CHF or MI, but better life quality
💥 does viability matter? For risk stratification
@VDelgadoGarcia @alexsfelixecho @Sarah_Moharem
REVIVED trial
💥 GDMT works — 90% on BB &ARNI/ACE/ ARB
💥 LVEF increase with PCI doesn’t help with CHF or MI, but better life quality
💥 does viability matter? For risk stratification
@VDelgadoGarcia @alexsfelixecho @Sarah_Moharem
• • •
Missing some Tweet in this thread? You can try to
force a refresh
